These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20713679)

  • 1. Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
    Khanna A; Raj VS; Tarai B; Sood R; Pareek PK; Upadhyay DJ; Sharma P; Rattan A; Saini KS; Singh H
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4789-93. PubMed ID: 20713679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
    Syed RR; Catanzaro DG; Colman RE; Cooney CG; Linger Y; Kukhtin AV; Holmberg RC; Norville R; Crudu V; Ciobanu N; Codreanu A; Seifert M; Hillery N; Chiles P; Catanzaro A; Rodwell TC
    J Clin Microbiol; 2023 Mar; 61(3):e0147822. PubMed ID: 36757183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
    Jnawali HN; Hwang SC; Park YK; Kim H; Lee YS; Chung GT; Choe KH; Ryoo S
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):187-96. PubMed ID: 23561273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
    Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
    BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.
    Dymova MA; Cherednichenko AG; Alkhovik OI; Khrapov EA; Petrenko TI; Filipenko ML
    BMC Infect Dis; 2014 Sep; 14():478. PubMed ID: 25186134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.
    Sowajassatakul A; Prammananan T; Chaiprasert A; Phunpruch S
    BMC Microbiol; 2014 Jun; 14():165. PubMed ID: 24953243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China.
    Hu Y; Hoffner S; Wu L; Zhao Q; Jiang W; Xu B
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3857-63. PubMed ID: 23733477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India.
    Ajbani K; Rodrigues C; Shenai S; Mehta A
    J Clin Microbiol; 2011 Apr; 49(4):1588-90. PubMed ID: 21289142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
    Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
    Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
    J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of genetic determinants of multidrug and extensively drug-resistant Mycobacterium tuberculosis using oligonucleotide microchip].
    Zimenkov DV; Kulagina EV; Antonova OV; Surzhikov SA; Bespiatykh IuA; Shitikov EA; Il'ina EN; Mikhaĭlovich VM; Zasedatelev AS; Griadunov DA
    Mol Biol (Mosk); 2014; 48(2):251-64. PubMed ID: 25850294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.
    Jugheli L; Bzekalava N; de Rijk P; Fissette K; Portaels F; Rigouts L
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5064-8. PubMed ID: 19752274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries.
    Ajbani K; Lin SY; Rodrigues C; Nguyen D; Arroyo F; Kaping J; Jackson L; Garfein RS; Catanzaro D; Eisenach K; Victor TC; Crudu V; Gler MT; Ismail N; Desmond E; Catanzaro A; Rodwell TC
    Antimicrob Agents Chemother; 2015 Jan; 59(1):414-20. PubMed ID: 25367911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases.
    Bhanushali A; Atre S; Nair P; Thandaseery GA; Shah S; Kuruwa S; Zade A; Nikam C; Gomare M; Chatterjee A
    Microbiol Spectr; 2024 May; 12(5):e0277023. PubMed ID: 38597637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant
    Varghese B; Al-Hajoj S
    Am J Trop Med Hyg; 2017 May; 96(5):1066-1070. PubMed ID: 28500800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.
    Feuerriegel S; Cox HS; Zarkua N; Karimovich HA; Braker K; Rüsch-Gerdes S; Niemann S
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3353-6. PubMed ID: 19470506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of mutations conferring extensive drug resistance to Mycobacterium tuberculosis isolates in Pakistan.
    Ali A; Hasan R; Jabeen K; Jabeen N; Qadeer E; Hasan Z
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5654-9. PubMed ID: 21911575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.